Ceylon Cinnamon: Polyphenols, Metabolic Nutrition & Research

This page is part of the AMLApure Ingredient Science Library. It is intended for holistic, integrative, and nutrition-focused healthcare professionals and scientifically interested consumers. Content is educational and does not constitute medical advice.

Ceylon Cinnamon: Polyphenols, Nutrition & Human Research

What Is Ceylon Cinnamon?

Ceylon cinnamon (Cinnamomum verum J.Presl, synonymous with Cinnamomum zeylanicum Blume) is a tropical evergreen tree in the family Lauraceae, native to Sri Lanka (formerly Ceylon). It is the species most commonly referred to as “true cinnamon” in botanical and culinary contexts.

The spice is produced from the inner bark of the tree. Ceylon cinnamon quills are recognizable for their soft, papery texture, multi-layered structure, and comparatively mild, delicate flavor profile — distinguishing them from the thicker, harder, single-layered quills of Cassia cinnamon species.

Ceylon cinnamon has a centuries-long history as a culinary and nutritional spice. Traditional botanical medicine systems including Ayurveda and various Middle Eastern traditions have documented use of cinnamon bark for digestive and metabolic-related applications.

Ceylon vs. Cassia Cinnamon

This distinction is scientifically important. “Cinnamon” is not a single botanical species — the name applies commercially to the bark of several different Cinnamomum species, which differ meaningfully in botanical identity, phytochemical composition, and safety profile.

  • Ceylon cinnamon — Cinnamomum verum: native to Sri Lanka; “true cinnamon”; soft, multi-layered quills; very low coumarin content
  • Cassia cinnamon — Cinnamomum aromaticum: the most widely sold “cinnamon” in North American supermarkets; harder, single-layered quills; significantly higher coumarin content
  • Vietnamese/Saigon cinnamon — Cinnamomum loureiroi: intensely flavored; high coumarin
  • Indonesian cinnamon — Cinnamomum burmannii: widely used in commercial products; high coumarin

Coumarin is a naturally occurring compound found at very low levels in Ceylon cinnamon but at substantially higher levels in Cassia species. EFSA and the German BfR have established tolerable daily intake levels for coumarin based on hepatotoxicity concerns in sensitive individuals. For supplement use, Ceylon cinnamon’s lower coumarin content makes it the preferred species for long-term use at higher daily intake amounts.

Research translation note: A large proportion of published human clinical research on cinnamon and metabolic outcomes has used Cassia cinnamon or did not clearly specify the species. Research conducted with C. aromaticum cannot be automatically attributed to Ceylon cinnamon (C. verum).

Naturally Occurring Compounds

Ceylon cinnamon inner bark contains cinnamaldehyde (the primary volatile compound responsible for flavor and aroma), type-A procyanidins (polymeric polyphenols studied for metabolic properties), eugenol (a phenylpropanoid), coumarin (at very low levels in C. verum), and other phenolic compounds and phenolic acids.

Research translation note: The presence of these compounds in cinnamon bark does not establish that consuming Ceylon cinnamon delivers them to human tissues at biologically relevant concentrations, or that laboratory findings translate directly to human clinical outcomes.

Polyphenols & Antioxidant Research

Cinnamon bark has been studied in antioxidant research contexts due to its polyphenol content. Laboratory assays (DPPH, FRAP, ORAC) have reported antioxidant activity for cinnamon bark extracts. However, in vitro antioxidant assay results do not establish equivalent antioxidant effects in human tissues or measurable clinical outcomes in humans.

Ceylon Cinnamon & Metabolic Nutrition

Cinnamon has attracted substantial scientific research interest in the context of carbohydrate metabolism and glucose physiology. Research interest relates to: the presence of polyphenolic compounds — particularly type-A procyanidins — studied in relation to carbohydrate metabolism; proposed interactions with digestive enzyme activity and post-meal glucose physiology; and its traditional inclusion in plant-rich dietary patterns across South Asian and Middle Eastern food cultures.

Structure/function language boundary: This page does not claim that Ceylon cinnamon treats, prevents, or cures diabetes, hyperglycemia, insulin resistance, metabolic syndrome, or any other metabolic disease or disorder.

What Human Research Shows

Human clinical research on cinnamon and metabolic outcomes is a mixed and heterogeneous literature. Several meta-analyses have pooled data from multiple trials examining cinnamon supplementation in relation to fasting blood glucose, HbA1c, and lipid markers. Key limitations: most trials used Cassia cinnamon (not Ceylon), study designs and populations vary widely, effect sizes in positive trials are modest, and inconsistency across trials is high. The evidence base does not support claims that cinnamon supplementation reliably treats or prevents any metabolic disease.

Authoritative external resources: Cochrane Library | PubMed — Ceylon cinnamon human trials

Ceylon Cinnamon in the Glycanda™ Formulation

Ceylon cinnamon is included as an ingredient in the Glycanda™ Metabolic GLP-1 Support formula — a plant-based powder combining botanical extracts and prebiotic fibers formulated to support metabolic function, digestive balance, and gut microbiome balance.

The full Glycanda™ botanical ingredient blend includes amla, berberine, bitter melon, cinnamon, ginger, inulin, mulberry leaf extract, okra, slippery elm, spearmint, and white kidney bean extract.

AMLApure does not claim that Ceylon cinnamon or Glycanda™ treats or prevents any metabolic disease, lowers blood glucose as a medical therapy, or replaces pharmaceutical management of any condition. AMLApure does not claim clinically proven synergistic outcomes from the combination of ingredients in Glycanda™.

For AMLApure’s broader formulation philosophy and ingredient standards, see The AMLApure Ingredient & Quality Pledge.

Quality & Formulation Considerations

Botanical identity testing confirming Cinnamomum verum (and not Cassia species) is a critical quality step for Ceylon cinnamon ingredients. Inner bark sourcing (not bark chips, leaf, or root bark) should be confirmed. Coumarin content testing may be appropriate for concentrated cinnamon extracts intended for long-term supplement use. Third-party testing for identity, purity, and potency supports quality assurance.

Safety & Considerations

  • Glucose physiology: Individuals managing blood glucose with medication (insulin, metformin, GLP-1 agonists, SGLT-2 inhibitors, etc.) should consult their healthcare provider before use.
  • Coumarin (Cassia species): High-dose long-term use of Cassia-type cinnamon carries hepatotoxicity risk in sensitive individuals due to high coumarin. Ceylon cinnamon’s very low coumarin content makes it the preferred species for supplement use.
  • Pregnancy: Cinnamon at normal culinary amounts is generally recognized as safe; concentrated supplement doses during pregnancy have insufficient safety data. Consult a healthcare provider.
  • Medication interactions: Consult your pharmacist or physician before use with prescription medications, particularly anticoagulants and antidiabetic agents.

Never modify or discontinue prescribed medical treatment in favor of a dietary supplement without medical supervision.

This educational content is not a substitute for professional medical advice, diagnosis, or treatment.

Frequently Asked Questions

What is Ceylon cinnamon?

Ceylon cinnamon (Cinnamomum verum) is the botanical species considered “true cinnamon,” native to Sri Lanka. It differs from Cassia cinnamon species in its softer quill structure, more delicate flavor, and significantly lower coumarin content — making it the preferred species for long-term supplement use.

What is the difference between Ceylon and Cassia cinnamon?

They are different botanical species with different phytochemical profiles. The most practically important difference for supplement users is coumarin content: Ceylon cinnamon contains very low levels; Cassia species contain substantially higher levels that can raise hepatotoxicity concerns at higher daily supplement doses. Most “cinnamon” sold in North American supermarkets is Cassia, not Ceylon.

Why is Ceylon cinnamon included in Glycanda™?

Its inclusion reflects the formulation’s multi-ingredient botanical approach to metabolic and digestive wellness, combining ingredients with complementary traditional use backgrounds and research profiles in metabolic nutrition. AMLApure does not claim that cinnamon or Glycanda™ treats or prevents any disease, or that the combination produces proven synergistic clinical outcomes.

References & Further Reading

  • Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. 2011;14(9):884–889. PubMed
  • European Food Safety Authority (EFSA). Opinion on coumarin in flavourings and other food ingredients. EFSA Journal. 2008;793:1–20.
  • NIH NCCIH — nccih.nih.gov
  • PubMed: Cinnamomum verum clinical research

← Ingredient Science Library   •   Glycanda™ Formulation →

This page is part of the AMLApure Ingredient Science Library. Content is educational and does not constitute medical advice. These statements have not been evaluated by the FDA. AMLApure products are not intended to diagnose, treat, cure, or prevent any disease.